Inhaltsbereich
2017
- Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.
(pdf, 8,35 MB)
Altenburg A.F., Sandt C.E. van de, Li B.W.S., MacLoughlin R.J., Fouchier R.A.M., Amerongen G. van, Volz A., Hendriks R.W., Swart R.L. de, Sutter G., Rimmelzwaan G.F., Vries R.D. de.
Sci. Rep., 7(1), Art. Nr. 8580 (2017) doi:10.1038/s41598-017-08719-y
- Sus scrofa papillomavirus 2 - genetic characterization of a novel suid papillomavirus from wild boar in Germany.
(pdf, 786 KB)
Link E.K., Hoferer M., Strobel B., Rigbers K., Langenmayer M.C., Sutter G., Fux R.
J. Gen. Virol., 98(8), 2113-2117 (2017)
- A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells. (pdf, 1,89 MB)
Link E.K., Brandmüller C., Suezer Y., Ameres S., Volz A., Moosmann A., Sutter G., Lehmann M.H.
Vaccine, 35(38), 5131-5139 (2017)
- Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens. (pdf, 5,6 M)
Tan W.G., Zubkova I., Kachko A., Wells F., Adler H., Sutter G., Major M.E.
PLoS ONE 12(7):e0181578 (2017)
- Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells. (pdf, 1,56 MB)
Frey T.R., Lehmann H.M., Ryan C.M., Pizzorno, M.C., Sutter G., Hersperger A.R.
Virology 509, 98-111 (2017)
-
Eddicks M., Szikora F., Walhöfer N., Sauter-Louis C., Reese S., Banholzer E., Reiner G., Sutter G., Ritzmann M.,
Fux R.
Tierärztl. Prax., Ausg.(G), 45(2), 90-97 (2017)
- Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
Rappuoli R., Sutter G.
Curr. Opin. Virol., 23, vi-viii (2017)
- Modified Vaccinia virus Ankara: History, value in basic research, and current perspectives for vaccine development. (pdf, 11 MB)
Volz A., Sutter G.
Advances in Virus Res., 97, 187-243 (2017)
Verantwortlich für den Inhalt:
Corina Macheel
